港股異動 | 珩灣科技(1523.HK)續升12%再度破頂 績後3日累計漲幅達30%
格隆匯7月30日丨珩灣科技(1523.HK)盤中再度大漲12%,3日累計升幅達30%,最高報2.53港元續刷歷史新高價,總市值近30億港元。珩灣科技27日公吿,上半年擁有人應占利潤929.2萬美元,同比大增81.5%。報吿期間內,北美洲的銷售額按年增長約32.9%至約1810.6萬美元;歐洲、中東及非洲地區的銷售額按年增長約49.7%至約936.6萬美元。所有地理區域的銷售額在此期間均出現了廣泛的增長,這是由於對公司的Speed Fusion技術提供的高度可靠連接的需求普遍增加。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.